![Elyse Stock](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elyse Stock
Direktör/Styrelseledamot på
Areteia Therapeutics, Inc.
Profil
Elyse Stock is currently a Director at Areteia Therapeutics, Inc. Prior to her current position, she worked as the Chief-Portfolio Strategy & Development at Biohaven Pharmaceutical Holding Co. Ltd. from 2017 to 2019.
She earned a doctorate degree from New York University School of Medicine.
Aktiva positioner av Elyse Stock
| Företag | Position | Start |
|---|---|---|
Areteia Therapeutics, Inc.
 Areteia Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Direktör/Styrelseledamot | 2023-04-17 |
Tidigare kända positioner av Elyse Stock
| Företag | Position | Slut |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Teknisk/Vetenskaplig/F&U Direktör | 2022-10-03 |
Elyse Stocks utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
13
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric diseases | Health Technology |
Areteia Therapeutics, Inc.
Areteia Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
